No insider purchase over the last 90 days. The latest, by KAIRAV CHEMICALS LIMITED, was filed 31 Dec 2025.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analysts rate Astral Limited Buy (bullish), based on 29 analysts. Average price target: ₹1,741.10.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended March 2026 · cache
25 of 57 declarations
At Astral Limited, an Indian industrial company valued at INR 375.7 billion, sales are numerous, 40 worth EUR 5.5 million (median EUR 57,815), and purchases rare but heavy: 6 worth EUR 4.4 million, median EUR 681,492. Purchases form only 13% of open-market trades.
On August 18, 2025, Saumya Polymers LLP bought EUR 1,291,026 and Kairav Chemicals Limited EUR 1,289,790; Kairav Chemicals Limited came back on September 23, 2025 for EUR 681,786. On December 30, 2025, 2 filers bought another EUR 461,220. Sales are more scattered: Bharatbhai Karshanbhai Patel, EUR 1,074,086 on June 5, 2023, and Hiranand Savlani HUF, EUR 679,440 on June 26, 2024 and EUR 528,338 on June 28, 2023.
Among the 25 filers are relatives: Aditya Sujal Shroff and Sanjana Sujal Shroff (Immediate relative) file 5 and 4 filings, all sales. The record holds 57 filings, 22 of them in 2023 against 2 in 2026, and 6 in the last twelve months, including 2 purchases and 4 sales. Insiders hold 54.3% of the capital.